Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Connolly

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109bPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
Physical Review Letters|December 9, 2022
Microwave Susceptibility Observation of Interacting Many-Body Andreev StatesV Fatemi, P D Kurilovich, M Hays, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biologyJohn W Adams, Juan Ramirez, Yunqing Shi, et al.
Journal of Lipid Research|October 3, 2000
Inhibition of cholesteryl ester transfer protein by substituted dithiobisnicotinic acid dimethyl ester: involvement Of a critical cysteineH R Hope, D Heuvelman, K Duffin, et al.
Journal of Clinical Lipidology|February 5, 2011
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humansEseng Lai, M Gerard Waters, James R Tata, et al.
Biochemistry|November 15, 2000
Stereospecific inhibition of CETP by chiral N,N-disubstituted trifluoro-3-amino-2-propanolsD T Connolly, B J Witherbee, M A Melton, et al.
Journal of the American Dental Association (1939)|February 1, 2024
Optimizing radiation safety in dentistry: Clinical recommendations and regulatory considerationsErika Benavides, Joseph R Krecioch, Roger T Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2007
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109aPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
JACC. Heart Failure|March 26, 2024
Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse PopulationsPhilip B Adamson, Melvin Echols, Ersilia M DeFilippis, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109bPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
Physical Review Letters|December 9, 2022
Microwave Susceptibility Observation of Interacting Many-Body Andreev StatesV Fatemi, P D Kurilovich, M Hays, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biologyJohn W Adams, Juan Ramirez, Yunqing Shi, et al.
Journal of Lipid Research|October 3, 2000
Inhibition of cholesteryl ester transfer protein by substituted dithiobisnicotinic acid dimethyl ester: involvement Of a critical cysteineH R Hope, D Heuvelman, K Duffin, et al.
Journal of Clinical Lipidology|February 5, 2011
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humansEseng Lai, M Gerard Waters, James R Tata, et al.
Biochemistry|November 15, 2000
Stereospecific inhibition of CETP by chiral N,N-disubstituted trifluoro-3-amino-2-propanolsD T Connolly, B J Witherbee, M A Melton, et al.
Journal of the American Dental Association (1939)|February 1, 2024
Optimizing radiation safety in dentistry: Clinical recommendations and regulatory considerationsErika Benavides, Joseph R Krecioch, Roger T Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2007
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109aPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
JACC. Heart Failure|March 26, 2024
Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse PopulationsPhilip B Adamson, Melvin Echols, Ersilia M DeFilippis, et al.
Pageof 17